Research location
Paris
Paris, France
Advertisement
Research activity in Paris
Paris, FranceCureCurrent currently publishes aggregate city-level research activity for this location: 86 trials and 94 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Paris
85 linked trials · page 1 of 2KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial DiseasesNCT06451757 · 2026-04-14 · 1 site observation
RECRUITING
Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN VaccineNCT06885853 · 2025-05-07 · 1 site observation
RECRUITING
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)NCT06881784 · 2025-05-06 · 1 site observation
RECRUITING
Prevalence, Determinants and Consequences of Dyspnea During Weaning in Critically Ill Obese PatientsNCT06867354 · 2025-03-21 · 1 site observation
RECRUITING
Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World ContextNCT06487078 · 2025-01-20 · 1 site observation
RECRUITING
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsNCT06784193 · 2024-12-16 · 1 site observation
RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationNCT05552157 · 2024-11-22 · 1 site observation
RECRUITING
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationNCT06647498 · 2024-11-22 · 1 site observation
RECRUITING
Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia RelapsesNCT06613334 · 2024-10-04 · 1 site observation
RECRUITING
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAHNCT06350032 · 2024-07-31 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)NCT06330064 · 2024-04-10 · 1 site observation
RECRUITING
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT06236438 · 2024-04-10 · 1 site observation
RECRUITING
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic ShockNCT04020263 · 2023-07-03 · 1 site observation
RECRUITING
Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psychiatric DisordersNCT05866991 · 2023-02-01 · 1 site observation
RECRUITING
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT04928846 · 2022-03-25 · 2 site observations
RECRUITING
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.NCT05050864 · 2022-03-02 · 1 site observation
RECRUITING
Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over TrialNCT06811402 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Hormonal and Microbiota Modulation After Endoscopic Sleeve GastroplastyNCT07576777 · 2026-05-04 · 1 site observation
NOT_YET_RECRUITING
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionNCT07128199 · 2025-12-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Role of Viral Reservoir, Immune Activation and Depletion in Persistent Viremia Persistent Viremia in People Living With HIV on Antiretroviral TherapyNCT07015164 · 2025-06-10 · 1 site observation
NOT_YET_RECRUITING
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised LipodystrophyNCT06502990 · 2025-05-23 · 1 site observation
TERMINATED
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)NCT06018337 · 2024-01-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%NCT05659563 · 2023-07-20 · 1 site observation
COMPLETED
EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.NCT03845751 · 2023-03-07 · 1 site observation
COMPLETED
A Chart Review Study of Adults With Advanced NSCLCNCT05207423 · 2022-10-03 · 1 site observation
COMPLETED
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of AgeNCT05399888 · 2022-08-24 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseNCT05310071 · 2022-06-02 · 1 site observation
TERMINATED
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)NCT05269394 · 2021-12-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple SclerosisNCT04777539 · 2021-06-14 · 2 site observations
COMPLETED
Comparison of the Performance of an Optimized 3D EPI SWI Sequence and a Non-EPI QSM SWI Sequence in Detecting the Central Vein Sign in Patients With Multiple SclerosisNCT04705870 · 2021-06-02 · 1 site observation
COMPLETED
Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid TumorsNCT04721015 · 2021-02-23 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 1 site observation
COMPLETED
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic MutationNCT06424236 · 2020-06-03 · 1 site observation
TERMINATED
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205NCT04241068 · 2020-03-02 · 1 site observation
TERMINATED
Study of DF1001 in Patients With Advanced Solid TumorsNCT04143711 · 2019-11-11 · 1 site observation
COMPLETED
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsNCT03893955 · 2019-05-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Serious Game in the Therapeutic Education of Type 1 Diabetes Paediatric PatientsNCT03520855 · 2019-04-03 · 1 site observation
COMPLETED
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseNCT03887455 · 2019-03-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]NCT03734029 · 2018-12-27 · 1 site observation
COMPLETED
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerNCT03539536 · 2018-10-10 · 1 site observation
ACTIVE_NOT_RECRUITING
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]NCT03523585 · 2018-08-01 · 1 site observation
COMPLETED
Study of Dose Escalation of Abiraterone Actetate in Prostate CancerNCT03458247 · 2018-06-22 · 1 site observation
COMPLETED
Assay for the Pancreatic Polypeptide: an Help for Clinical Practice Guidelines in Classification of the DiabetesNCT03396146 · 2018-06-14 · 1 site observation
COMPLETED
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's DiseaseNCT03352557 · 2018-05-03 · 1 site observation
TERMINATED
Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.NCT03164473 · 2018-03-07 · 1 site observation
COMPLETED
Respiratory Outcome of Children From the FEPED CohortNCT03229317 · 2018-01-31 · 3 site observations
COMPLETED
Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévèreNCT03339817 · 2018-01-11 · 1 site observation
COMPLETED
Trans-rectal Focal Microwave Ablation of the Index Tumor in Patients With Low-risk Prostate CancerNCT03023345 · 2017-09-12 · 1 site observation
COMPLETED
PET/CT Guided Antifungal Stewardship in Invasive Pulmonary AspergillosisNCT02955966 · 2017-06-02 · 1 site observation
COMPLETED
Treatment Tapering in JIA With Inactive DiseaseNCT02840175 · 2017-05-18 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.